Skip to main content
SpringerLink
Log in

Deaths linked with new use of PPIs assessed in US veterans

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Among the new users of PPIs, almost 59% of all initial PPI prescriptions were for rabeprazole 20mg once daily, almost 22% were for omeprazole 20mg once daily, and approximately 8% were for rabeprazole 20mg twice daily.

Reference

  • Xie Y, et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ 365: [13 pages], 30 May 2019. Available from: URL: https://doi.org/10.1136/bmj.l1580

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deaths linked with new use of PPIs assessed in US veterans. Reactions Weekly 1756, 3 (2019). https://doi.org/10.1007/s40278-019-62882-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-62882-z

Search

Navigation